Sort
53,477 grants matching “addiction”
Elucidation of Leukocyte and Macrophage Biomarker Signatures from Drugs of Abuse
$1,169,938John Alan McLean · Vanderbilt University · RC2 · FY2010 · DA
Prapela⢠SVS: A cost-effective stochastic vibrotactile stimulation device toimprove the clinical course of infants with neonatal abstinence syndrome.
$1,169,404John Phillip Konsin · Prapela, Inc. · R44 · FY2022 · DA
Sleep and circadian rhythm phenotypes and mechanisms associated with opioid use disorder treatment outcomes
$1,169,398Andrew S Huhn · Johns Hopkins University · R01 · FY2025 · DA
Clinical Trials Network: The Texas Node
$1,168,862Madhukar H Trivedi · Ut Southwestern Medical Center · UG1 · FY2016 · DA
Neuronal connectivity within the mesolimbic system
$1,168,748Marisela Morales · National Institute On Drug Abuse · ZIA · FY2015 · DA
Preclinical Testing of Antibody Therapy for METH Abuse
$1,166,679University Of Arkansas Med Scis Ltl Rock · P01 · FY2004 · DA
Mechanisms of Transcriptional Control by p300
$1,165,943Kevin Gardner · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Maternal Opioid Treatment: Human Experimental Research
$1,165,849Hendree E. Jones · Johns Hopkins University · R01 · FY2006 · DA
Integrating Addiction and Infectious Diseases Services into Primary Care in Rural Settings
$1,165,515Frederick Lewis Altice · Yale University · R01 · FY2022 · DA
CENTER ON INTERSYSTEM REGULATION BY DRUGS OF ABUSE
$1,164,610Temple University · P30 · FY2002 · DA
Novel interventions to reduce stress induced non-homeostatic eating
$1,164,543Elissa S. Epel · University Of California, San Francisco · U01 · FY2009 · HL
Fructokinase Inhibitors for the Treatment of Alcohol Use Disorder
$1,163,856Richard Joseph Johnson · Colorado Research Partners, Llc · U01 · FY2022 · AA
CENTER ON INTERSYSTEM REGULATION BY DRUGS OF ABUSE
$1,163,568Temple University · P30 · FY2004 · DA
New England Regional Primate Research Center
$1,163,488Joseph B Martin · Harvard Medical School · P51 · FY2006 · RR
Sleep and circadian rhythm phenotypes and mechanisms associated with opioid use disorder treatment outcomes
$1,163,257Andrew S Huhn · Johns Hopkins University · R01 · FY2024 · DA
The Florida Node Alliance of the National Drug Abuse Treatment Clinical Trials Network
$1,163,175Jose Szapocznik · University Of Miami School Of Medicine · UG1 · FY2019 · DA
Effects of Medication for Opioid Use Disorder on Microglial Activation and Neurocognition in People Living with HIV
$1,162,746Shelli Farhadian · Yale University · R01 · FY2025 · DA
Clinical Trials Network Mid-Atlantic Collaborative Group
$1,162,492Maxine L Stitzer · Johns Hopkins University · U10 · FY2010 · DA
Characterization of neuronal ensembles activated during drug-induced behavior
$1,161,958Bruce Hope · National Institute On Drug Abuse · ZIA · FY2010 · DA
The Impact of HIV Infection on Immunologic, Transcriptomic, and Metabolomic Signatures of Medication-Assisted Therapy for Opioid Addiction
$1,161,477Sandra Ann Springer · Yale University · R01 · FY2016 · DA
Preclinical Testing of Antibody Therapy for METH Abuse
$1,161,210University Of Arkansas Med Scis Ltl Rock · P01 · FY2003 · DA
Center for Study of Opioid Receptors and Drugs of Abuse (CSORDA)
$1,160,461Christopher J Evans · University Of California Los Angeles · P50 · FY2007 · DA
Multiplex Imaging of Brain Activity and Plasticity with Optimized FRET/FLIM-based Sensors
$1,159,614Daniel A Dombeck · Northwestern University · U01 · FY2023 · NS
Neurobiology of Psychostimulant and Opiate Addiction
$1,159,607Toni Shippenberg · National Institute On Drug Abuse · Z01 · FY2007 · DA
Molecular determinants of ensemble recruitment by drugs of abuse
$1,159,396Erin Calipari · Vanderbilt University · R01 · FY2025 · DA